A detailed history of Girard Partners Ltd. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Girard Partners Ltd. holds 35,017 shares of LNTH stock, worth $2.76 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
35,017
Previous 19,932 75.68%
Holding current value
$2.76 Million
Previous $1.24 Million 76.44%
% of portfolio
0.21%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$51.07 - $68.26 $770,390 - $1.03 Million
15,085 Added 75.68%
35,017 $2.18 Million
Q4 2023

Feb 09, 2024

SELL
$55.6 - $77.89 $303,631 - $425,357
-5,461 Reduced 21.51%
19,932 $1.24 Million
Q3 2023

Nov 02, 2023

BUY
$60.27 - $90.75 $629,580 - $947,974
10,446 Added 69.89%
25,393 $1.76 Million
Q2 2023

Aug 15, 2023

BUY
$82.41 - $99.65 $1.23 Million - $1.49 Million
14,947 New
14,947 $1.25 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.42B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.